Antidepressant Discontinuation and Risk of Suicide Attempt: A Retrospective, Nested Case-Control Study
The DOI matches its Crossref record, with a small difference in title or year; 9 of the 9 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Prior efforts to assess the impact of antidepressant use on risk of suicide attempt focused on antidepressant initiation or duration of use. Gaps remain in understanding risks associated with antidepressant discontinuation in the context of the drug regimen. We assessed the effects of antidepressant discontinuation on the risk of suicide attempt. METHOD: We report a nested case-control study of suicide attempt with at least 12 months of prior observation. A retrospective cohort of 2.4 million patients with depression (ICD-9 codes 296.2, 296.3, 300.4, and 311), aged 5-89 years, was created using standard Healthcare Effectiveness Data and Information Set (HEDIS) criteria; from this cohort, cases (n = 10,456) and controls (n = 41,815) were selected for study. Data were from a large, national, longitudinal, integrated claims database of managed care enrollees in the United States from calendar years 1999 through 2006. RESULTS: Compared to controls, cases were more likely to have used antidepressants, to have had multiple antidepressants, and to have had prior depressive episodes and inpatient stays that involved depression. After adjusting for confounding due to depression severity, comorbidities, and other medications, antidepressant use showed a protective effect for suicide attempt (OR = 0.62, P < .001). Compared to prior therapy, antidepressant discontinuation had a significant risk for suicide attempt (OR = 1.61, P < .05). Antidepressant initiation had the highest risk for suicide attempt (OR = 3.42, P < .05), followed by titration (titration up, OR = 2.62; down, OR = 2.19; P < .05). CONCLUSIONS: Substantial confounding exists in examining the link between antidepressant use and suicide attempt, specifically regarding those factors associated with characteristics of depression. Antidepressant discontinuation showed a significant risk for suicide attempt, as did the period of an abbreviated trial, that is, stopping before a therapeutic regimen of 56 days had been reached. The highest risk was associated with initiation, a finding consistent with other studies, closely followed by periods of dosing changes and discontinuation. Patients should be closely monitored during these periods.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However,”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Valuck 2009
In the citing paper
“The conclusion that suicide was”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Valuck 2009
In the citing paper
“In one study, the syndrome lasted for at least twelve weeks in 25% of patients 18 , and in another for at least six weeks in 40% of people 20 .A third study reported that 86.7% responded that the syndrome had lasted at least two months, 58.6% at least one year, and 16.2% for more than three years 21 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [20]
In the citing paper
“Fluoxetine should take 35-75 days to reach steady state 49 , a fact that is likely responsible for observations that its withdrawal symptoms can arise weeks after cessation 9,20 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [20]
Citations
Cites
Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086 · cited 1×
“In their metaanalyses of antidepressant clinical trials, however, the FDA noted that there were no completed suicides and only infrequent suicide attempts reported in the trials.(4,5) Only when the endpoints of suicidal ideation and “possible” suicidal ideation were included did the meta-analyses yield significant eff…”
BackgroundSuicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054 · cited 1×
“In their metaanalyses of antidepressant clinical trials, however, the FDA noted that there were no completed suicides and only infrequent suicide attempts reported in the trials.(4,5) Only when the endpoints of suicidal ideation and “possible” suicidal ideation were included did the meta-analyses yield significant eff…”
BackgroundPosner, K., Oquendo, M. A., Gould, M., Stanley, B., & Davies, M. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1035 · Cited by 1,025 · cited 1×
“Suicidality is a term that encompasses a large range of behaviors and thoughts, including completed suicide, suicide attempt, planning or other preparatory action, and suicidal ideation.(1) Concern over a possible link between suicidality and antidepressant use has led the US Food and Drug Administration (FDA) to take…”
BackgroundSuicide Risk During Antidepressant Treatment
Simon, G. E., Savarino, J., Operskalski, B., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.41 · Cited by 424
Decline in Treatment of Pediatric Depression After FDA Advisory on Risk of Suicidality With SSRIs
Libby, A. M., Brent, D. A., Morrato, E. H., Orton, H. D., Allen, R., & Valuck, R. J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.884 · Cited by 281 · cited 1×
“Prescriber type for the antidepressant was indicated as primary care physician (internist, family medicine practitioner, obstetrician/gynecologist), psychiatrist, other mental health specialist (psychologist, social worker, psychiatric nurse), other non–mental health specialist, or other physician/unknown specialty ty…”
BackgroundSelf-citationValuck, R. J., Libby, A. M., Sills, M. R., Giese, A. A., & Allen, R. R. (2004) · CNS Drugs · doi:10.2165/00023210-200418150-00006 · Cited by 182 · cited 4×
“Consistent with Simon and colleagues,(7,19) our findings reveal the entire 55-day initiation period as the highest risk for suicide attempt, and consistent with our earlier pediatric work, longer duration reduced risk of suicide attempt.(8) The association between antidepressant use and the risk of suicidality is a cl…”
BackgroundMethodResultInfluentialSelf-citationSuicide Attempts Among Patients Starting Depression Treatment With Medications or Psychotherapy
Simon, G. E., & Savarino, J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1029 · Cited by 168 · cited 1×
“One cohort study showed an increase in suicide attempt risk in the month immediately prior to initiation of antidepressant therapy and in the first 4 to 8 weeks of therapy.(7) Another cohort study showed that suicide attempt risk decreased as duration of treatment increased.”
BackgroundIsotretinoin, pregnancies, abortions and birth defects: a population‐based perspective
Bérard, A., Azoulay, L., Koren, G., Blais, L., Perreault, S., & Oraichi, D. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02837.x · Cited by 113 · cited 1×
“Pregnancy was noted for any female patient in the observation period using ICD-9 codes and pregnancy-related procedure codes.(14) The following psychiatric disorders were included as indicator variables: bipolar disorder, schizophrenia, anxiety spectrum, substance use disorder, and other mental health problem.”
MethodNCQA Behavioral Health Measurement Efforts
Hudson, S. (2005) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2005.11.3.s9 · Cited by 16
Cited by
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
“Further, antidepressant discontinuation has been associated with an increased risk of suicide (Valuck et al., 2009).”
BackgroundNarouze, S., Benzon, H. T., Provenzano, D. A., Buvanendran, A., De Andres, J., Deer, T. R., Rauck, R., & Huntoon, M. A. (2015) · Regional Anesthesia and Pain Medicine · doi:10.1097/aap.0000000000000223 · Cited by 362
Tapering of SSRI treatment to mitigate withdrawal symptoms
Horowitz, M. A., & Taylor, D. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30032-x · Cited by 280
Narouze, S., Benzon, H. T., Provenzano, D., Buvanendran, A., De Andres, J., Deer, T., Rauck, R., & Huntoon, M. A. (2017) · Regional Anesthesia and Pain Medicine · doi:10.1097/aap.0000000000000700 · Cited by 164
Coupland, C., Dhiman, P., Barton, G., Morriss, R., Arthur, A., Sach, T., & Hippisley-Cox, J. (2011) · Health Technology Assessment · doi:10.3310/hta15280 · Cited by 141
Practical Suicide-Risk Management for the Busy Primary Care Physician
McDowell, A. K., Lineberry, T. W., & Bostwick, J. M. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0076 · Cited by 135
Jeon, H. J. (2011) · Journal of Korean Medical Association · doi:10.5124/jkma.2011.54.4.370 · Cited by 133
Toward personalizing treatment for depression: predicting diagnosis and severity
Huang, S. H., LePendu, P., Iyer, S. V., Tai-Seale, M., Carrell, D., & Shah, N. H. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002733 · Cited by 109
Elevated Risk of Preeclampsia in Pregnant Women With Depression: Depression or Antidepressants?
Palmsten, K., Setoguchi, S., Margulis, A. V., Patrick, A. R., & Hernández-Díaz, S. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr394 · Cited by 90
Van Leeuwen, E., van Driel, M. L., Horowitz, M. A., Kendrick, T., Donald, M., De Sutter, A. I., Robertson, L., & Christiaens, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495.pub2 · Cited by 90
Lerner, A., & Klein, M. (2019) · Brain Communications · doi:10.1093/braincomms/fcz025 · Cited by 89
“Withdrawal of antidepressants and other CNS drugs such as BZ and stimulants may lead to dangerous, even lifethreatening, withdrawal symptoms and lead to significant public health concerns, such as suicidality (Risse et al., 1990; Valuck et al., 2009; APA, 2013; Fava et al., 2015).”
BackgroundThe impact of Ayahuasca on suicidality: results from a randomized controlled trial
Zeifman, R. J., Palhano-Fontes, F., Hallak, J., Arcoverde, E., Maia-Oliveira, J. P., & Araujo, D. B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01325 · Cited by 87
“For instance, ECT (Tanney, 1986; Prudic and Sackeim, 1999; Kellner et al., 2005) and traditional interventions for suicidality require ongoing administration in order to maintain their antisuicidal effects (Valuck et al., 2009).”
Background(2022) · doi:10.1192/bja.2021.62 · Cited by 73
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data
Horowitz, M. A., Framer, A., Hengartner, M. P., Sørensen, A., & Taylor, D. (2023) · CNS Drugs · doi:10.1007/s40263-022-00960-y · Cited by 76
“Severe withdrawal effects can lead to misdiagnosis of other medical conditions or a misdiagnosis of relapse [8, 9], presentations to the emergency department [10] and suicide attempts [11].”
BackgroundResultHengartner, M. P., & Plöderl, M. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000501215 · Cited by 56
Use of Serotonergic Antidepressants and Bleeding Risk in Patients Undergoing Surgery
Jeong, B.-O., Kim, S., Kim, S., Kim, J., Shin, I., & Yoon, J. (2013) · Psychosomatics · doi:10.1016/j.psym.2013.08.011 · Cited by 51
Efeito rebote dos fármacos modernos: evento adverso grave desconhecido pelos profissionais da saúde
Teixeira, M. Z. (2013) · Revista da Associação Médica Brasileira · doi:10.1016/j.ramb.2013.05.003 · Cited by 58
Bosker, F. J., Tanke, M. A. C., Jongsma, M. E., Cremers, T. I. F. H., Jagtman, E., Pietersen, C. Y., van der Hart, M. G. C., Gladkevich, A. V., Kema, I. P., Westerink, B. H. C., et al. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.10.001 · Cited by 40
“One recent systematic study has corroborated these incidental suicide reports (Simon and Savarino, 2007), whereas another suggested that the highest risk of suicide was associated with initiation of treatment, closely followed by dosing changes and discontinuation (Valuck et al., 2009).”
Studies of Long-Term Use of Antidepressants: How Should the Data from Them be Interpreted?
El-Mallakh, R. S., & Briscoe, B. (2012) · CNS Drugs · doi:10.2165/11599450-000000000-00000 · Cited by 36
Karkow, D., Kauer, J., & Ernst, E. J. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000751 · Cited by 36
Alsheikh, M. Y. (2021) · Archives of Pharmacy Practice · doi:10.51847/ioicfujpnm · Cited by 34
“Withdrawal effects involve a variety of physical, mental, and emotional signs and symptoms, some of which are serious, potentially life-threatening, or fatal if not addressed properly [1-3].”
BackgroundAlbrecht, J. S., Kiptanui, Z., Tsang, Y., Khokhar, B., Smith, G. S., Zuckerman, I. H., & Simoni, J. M. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2014.3651 · Cited by 34
“Discharge to Skilled Nursing Facility, n (%) 2205 (46) 1872 (40) 15,053 (33) Length of TBI hospital stay, n (%) 0–2 days 1212 (25) 1063 (23) 12,380 (27) 3–5 days 1905 (39) 1732 (37) 16,242 (35) 6–8 days 710 (15) 777 (17) 6844 (15) 9 or more days 1014 (21) 1096 (24) 10,753 (23)”
Horowitz, M., & Wilcock, M. (2022) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2020.000080 · Cited by 33
Antidepressant utilization patterns and mortality in Swedish men and women aged 20–34 years
Sundell, K. A., Gissler, M., Petzold, M., & Wærn, M. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0933-z · Cited by 31
“and suicide in particular, [10, 14, 15], among antidepressant users whereas others do not [16, 17].”
BackgroundResultQian, J., Simoni‐Wastila, L., LANGENBERG, P. W., Rattinger, G. B., Zuckerman, I. H., Lehmann, S. W., & Terrin, M. C. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12220 · Cited by 29
Should Antidepressants be Avoided in Pregnancy?
Besag, F., & Vasey, M. J. (2022) · Drug Safety · doi:10.1007/s40264-022-01257-1 · Cited by 33
“In the general population, antidepressant discontinuation is associated with a significant risk of suicide attempts [104].”
BackgroundAntidepressants and Bleeding Risk After Face-lift Surgery
Harirchian, S., Zoumalan, R. A., & Rosenberg, D. B. (2012) · Archives of Facial Plastic Surgery · doi:10.1001/archfaci.2012.2 · Cited by 29
Wei, Y. J., Simoni‐Wastila, L., Albrecht, J. S., HUANG, T.-Y. J., Moyo, P., Khokhar, B., Harris, I., LANGENBERG, P. W., Netzer, G., & Lehmann, S. W. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4772 · Cited by 26
Immunomodulatory drugs (natalizumab), worsening of multiple sclerosis, rebound effect and similitude
Teixeira, M. Z. (2013) · Homeopathy · doi:10.1016/j.homp.2013.05.001 · Cited by 30
Averill, L. A., & Abdallah, C. G. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2035358 · Cited by 23
“as there are implications for increased suicide risk during the potentially required taper from SSRIs, for example [48,49].”
BackgroundJain, R., Chen, D., Edwards, J., & Mathews, M. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.855188 · Cited by 21
Selective Serotonin Reuptake Inhibitors: How Long Is Long Enough?
Thom, R. P., Alexander, J. L., Baron, D. A., Garakani, A., Gross, L. S., Pine, J. H., Radhakrishnan, R., Slaby, A. E., & Sumner, C. R. (2021) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000578 · Cited by 21
Schechter, M., Goldblatt, M. J., Ronningstam, E. F., Herbstman, B., & Maltsberger, J. T. (2016) · Bulletin of the Menninger Clinic · doi:10.1521/bumc.2016.80.1.80 · Cited by 21
Sørensen, J. Ø., Rasmussen, A., Roesbjerg, T., Verhulst, F. C., & Pagsberg, A. K. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13360 · Cited by 21
Qian, J., Simoni, J. M., Rattinger, G. B., Lehmann, S. W., LANGENBERG, P. W., Zuckerman, I. H., & Terrin, M. C. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.06.005 · Cited by 19
“Depression severity indicators included (a) the presence of a fifth digit depression diagnosis code of “4” (severe with mention of psychosis) [35] and (b) any evidence of psychiatric hospitalization with a primary diagnosis of depression [36,37].”
MethodDo antidepressants make children and adolescents suicidal?
Gordon, M. S., & Melvin, G. A. (2014) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.12655 · Cited by 17
Marwood, L., Croal, M., Mistry, S. J., Simmons, H., Tsai, J., Young, M. B., & Goodwin, G. M. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.10.009 · Cited by 16
Huo, S., Bruckner, T. A., Xiong, G. L., Cooper, E. C., Wade, A. J., Neikrug, A. B., Gagliardi, J. P., & McCarron, R. M. (2023) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-023-01290-x · Cited by 13
“Studies find that the greater prescriptions of antidepressants are associated with fewer suicides (Haukka et al., 2009; Henriksson & Isacsson, 2006; Valuck et al., 2009).”
BackgroundSimilia similibus curentur: o princípio de cura homeopático fundamentado na farmacologia moderna
Teixeira, M. Z. (2013) · Revista de Medicina · doi:10.11606/issn.1679-9836.v92i3p183-203 · Cited by 20
Wu, C., Liao, S., Tsai, Y., Chang, S., & Tsai, H. (2016) · Psychological Medicine · doi:10.1017/s0033291716002257 · Cited by 14
“Some recent studies using claims data showed that the risk of suicide or self-harm might be different across antidepressants (Tiihonen et al. 2006; Valuck et al. 2009; Valenstein et al. 2012; Cheung et al. 2015; Coupland et al. 2015).”
BackgroundResultLes antidépresseurs préviennent le suicide... en attendant mieux !
Courtet, P., & Olié, É. (2014) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31294-4 · Cited by 17
Yao, Z., & McCall, W. V. (2023) · Pharmaceutical Medicine · doi:10.1007/s40290-023-00467-x · Cited by 16
Teixeira, M. Z. (2021) · International Journal of High Dilution Research · doi:10.51910/ijhdr.v13i49.714 · Cited by 16
Initial Dose of Antidepressant and Suicidal Behavior in Youth: Start Low, Go Slow
Brent, D. A., & Gibbons, R. D. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.14016 · Cited by 12
Foco, E. (2016) · Cited by 10
Su, K., Lü, N., Tang, C., Chiu, W., Chang, H.-C., & Huang, K.-C. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.03.039 · Cited by 11
Chitty, K. M., Buckley, N. A., Lim, J. S., Ali, Z., Schumann, J., Cairns, R. F., Daniels, B. J., Pearson, S., Preen, D. B., & Schaffer, A. L. (2023) · The Medical Journal of Australia · doi:10.5694/mja2.51985 · Cited by 10
Achieving adolescent adherence to treatment of major depression
Staton, D. (2010) · Adolescent Health Medicine and Therapeutics · doi:10.2147/ahmt.s8791 · Cited by 9
“Adherence is critically important because (1) antidepressant discontinuation is associated with significant risk of subsequent suicide attempt 5,138 and (2) a majority of treated adolescent suicide victims are reported to have been poorly or noncompliant prior to death.”
Castelpietra, G., Bortolussi, L., Gobbato, M., Arnoldo, L., Balestrieri, M., & Wettermark, B. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13140 · Cited by 7
Sørensen, J. Ø., Rasmussen, A., Roesbjerg, T., & Pagsberg, A. K. (2019) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-019-01435-0 · Cited by 8
Psychotropics and COVID-19: An analysis of safety and prophylaxis
Javelot, H., Straczek, C., Meyer, G., Faria, C. G. F., Weiner, L., Drapier, D., Fakra, É., Fossati, P., Weibel, S., Dizet, S., et al. (2021) · L Encéphale · doi:10.1016/j.encep.2021.08.002 · Cited by 6
Повышают ли антидепрессанты риск суицида?
Kasyanov, E. D., Rukavishnikov, G. V., Rozanov, V. A., & Mazo, G. E. (2019) · Суицидология · doi:10.32878/suiciderus.19-10-04(37)-85-98 · Cited by 8
“At the same time, some studies did not reveal differences between the risks of suicide when taking therapy and when it was canceled [28].”
BackgroundResultInfluentialThe depressed patient in a biological world: on philosophical and diagnostic strategies
Korf, J., & Bosker, F. J. (2013) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12049 · Cited by 7
“By causing serotonin unbalance and increased impulsivity, it may not only lead to further non-compliant behaviour but it might also facilitate suicidal behaviour [40].”
BackgroundFortier, L. M., Moyal, A. J., Dave, U., Burkhart, R. J., Adelstein, J. M., Strony, J. T., Sinkler, M. A., & Napora, J. K. (2025) · Injury · doi:10.1016/j.injury.2025.112236 · Cited by 5
Vallee, J., Wong, Y., Mannino, E., Nordeng, H., & Lupattelli, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18010046 · Cited by 5
“Antidepressant discontinuation poses a 60% increased risk for suicide attempt in non-pregnant subjects, although its effect on self-harm is unclear [22,51].”
BackgroundLadner, L. R., Shick, T. J., Adhikari, S., Marvin, E. A., Weppner, J. L., & Kablinger, A. S. (2024) · Journal of Neurotrauma · doi:10.1089/neu.2024.0167 · Cited by 7
Perinatal psychotropic dispensing: A descriptive population‐based study in N ew Z ealand
Broughton, L. C., Medlicott, N. J., Zeng, J., & Smith, A. J. (2023) · Asia-Pacific Psychiatry · doi:10.1111/appy.12539 · Cited by 4
Use of antidepressant medication and suicidal ideation—the Northern Finland Birth Cohort 1966
Rissanen, I. L., Jääskeläinen, E., Isohanni, M. K., Koponen, H., Joukamaa, M. I., Alaräisänen, A., & Miettunen, J. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2443 · Cited by 5
“In a study by Valuck et al. (2009), the use of antidepressant medication showed a protective effect for suicide attempts after adjustment for depression severity, comorbidities, and other medication.”
BackgroundBronisch, T. (2018) · NeuroTransmitter · doi:10.1007/s15016-018-6214-2 · Cited by 3
The Role of Antidepressants in Bipolar Disorder
Yerevanian, B. I. (2011) · Wiley eBooks · doi:10.1002/9780470975114.ch15 · Cited by 2
Ha, J. H., Lee, E., Lee, D. Y., Cho, Y. H., Lee, H., Park, B., & Son, S. J. (2020) · 신경정신의학 · doi:10.4306/jknpa.2020.59.3.243 · Cited by 2
[Celecoxib vs indomethacin and acute gastric lesions in rats].
Laudanno, O. M. O., Esnarriaga, J., Cesolari, J. A., Maglione, C. B., Aramberry, L. J., Sambrano, J. S., Piombo, G., & Rista, L. (2000) · PubMed · Cited by 2
Holsboer‐Trachsler, E., & Holsboer, F. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_53 · Cited by 2
Xu, C., Kim, T. T., Kirsch, I., Plöderl, M., Amsterdam, J. D., & Pigott, H. E. (2025) · medRxiv · doi:10.1101/2025.02.10.25321991 · Cited by 2
Wang, Y., Fahmi, A., Woodall, A., Ashcroft, D. M., Sperrin, M., & van Staa, T. P. (2026) · The British Journal of Psychiatry · doi:10.1192/bjp.2026.10588 · Cited by 1
Assessing Suicide Risk in Airline Pilots With Major Depression
Vuorio, A. F., Suhonen-Malm, A.-S., Budowle, B., Gray, A., Gordon, S., & Bor, R. J. (2026) · Aviation Psychology and Applied Human Factors · doi:10.1027/2192-0923/a000313 · Cited by 1
Yang, J. H., Kim, M. J., Rhee, S. J., Lee, H., Kim, Y., Lee, B., & Ahn, Y. M. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122364 · Cited by 1
Pharmacological Treatment of Suicidality in Affective and Psychotic Disorders
Bronisch, T. (2022) · Springer eBooks · doi:10.1007/978-3-030-42003-1_69 · Cited by 1
Kostic, M., Plöder, M., Hengartner, M., & Buzejic, J. (2024) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.23cr14930 · Cited by 1
The Components of Adherence for Depression Patients
Hung, Y., Wang, Y., & Chou, J. P. (2014) · doi:10.30074/fjmh.201406_27(2).0002 · Cited by 1
More to Look in the Diabetic Patients: Depression
Ellinger, V. (2015) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2015.02.00052
Primary Care Behavioral Health (PCBH) Model and Suicide
Smith, A. D., Fondow, M. D. M., & Schreiter, E. Z. (2018) · Springer eBooks · doi:10.1007/978-3-319-74391-2_8
Antidepressant Use by Youth with Minimal or Mild Depression: Evidence from 3 Health Systems
Penfold, R. B., Stewart, C. C., Simon, G. E., Shortreed, S. M., Johnson, E., Rossom, R. C., Operskalski, B. H., & Beck, A. L. (2017) · Pediatric Quality and Safety · doi:10.1097/pq9.0000000000000017
Hengartner, M. P., & Plöderl, M. (2019) · Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences) · doi:10.21256/zhaw-3179
GÜZEY, N. A., TÜRKYILMAZ, H. E. U., & Eryılmaz, N. C. (2021) · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · doi:10.38136/jgon.843714
Matamela, N. A. (2015) · Boloka Institutional Repository (North-west University)
Pharmacological Treatment of Suicidality in Affective and Psychotic Disorders
Bronisch, T. (2021) · Springer eBooks · doi:10.1007/978-3-030-41319-4_69-1
Laux, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_55
Management of Patients With Obsessive-Compulsive Disorder: Focus on Pharmacotherapy
Maziero, M. P., Macaya, D., Shavitt, R. G., Diniz, J. B., Miguel, E. C., da Silva, R. D. M. F., & Costa, D. L. D. C. (2022) · Psychiatric Annals · doi:10.3928/00485713-20220315-01
Acute Care Admission of the Behavioral Health Patient
(2014) · AORN Journal · doi:10.1016/j.aorn.2014.07.008
Introduction to Deprescribing Psychiatric Medications
(2024) · Wiley eBooks · doi:10.1002/9781394291052.mdg001
Safe Deprescribing of Antidepressants
(2024) · Wiley eBooks · doi:10.1002/9781394291052.mdg002
Onasanya, O., Damachi, U., dosReis, S., & Castillo, W. C. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70131
Suicide and affective disorders
Vázquez, G. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33580-8.00008-8
Mirzazadeh, A., Cadavid, S., Zha, K., Li, C., Alzahrani, S., Alawajy, M., Korzenik, J., Hoti, K., Reynolds, C. L., Mischoulon, D., et al. (2025) · arXiv (Cornell University) · doi:10.48550/arxiv.2510.10364
“In a U.S. cohort of 2.4 million patients, prematurely stopping an antidepressant heightened the odds of a suicide attempt by 61% 5 ; Similarly, U.K. data revealed peaks in self-harm and suicide during the first month after discontinuation.”
InfluentialGÜZEY, N. A., TÜRKYILMAZ, H. E. U., & Eryılmaz, N. C. (2020) · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Strawn, J. R., & Stahl, S. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009642187.060
Strawn, J. R., & Stahl, S. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009642187.056
Strawn, J. R., & Stahl, S. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009642187.048
Strawn, J. R., & Stahl, S. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009642187.015
Strawn, J. R., & Stahl, S. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009642187.009
Strawn, J. R., & Stahl, S. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009642187.014
Strawn, J. R., & Stahl, S. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009642187.031
Strawn, J. R., & Stahl, S. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009642187.027
Strawn, J. R., & Stahl, S. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009642187.003
Strawn, J. R., & Stahl, S. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009642187.036
Strawn, J. R., & Stahl, S. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009642187.021
Strawn, J. R., & Stahl, S. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009642187.046
Strawn, J. R., & Stahl, S. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009642187.062
Strawn, J. R., & Stahl, S. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009642187.045
Metadata
- Authors
- Valuck, R. J., Orton, H. D., & Libby, A. M.
- Affiliations
- University of Colorado Anschutz (US)
- Corresponding author
- Valuck, Robert J.
- ORCID
- Libby, Anne M.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2009-08-15
- Volume
- 70
- Issue
- 8
- Pages
- 1069-1077
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2077315601
- Cited by
- 106
- References
- 9
- Citations by year
- 2026: 22 · 2025: 4 · 2024: 5 · 2023: 4 · 2022: 6 · 2021: 9 · 2020: 3 · 2019: 9 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 4 · 2014: 8 · 2013: 9 · 2012: 3
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- antidepressant discontinuation, suicide attempts, depression, antidepressant initiation, antidepressant safety, depression severity, managed care claims data
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Antidepressive Agents, Child, Child, Preschool, Major Depressive Disorder, Dose-Response Relationship, Drug, Drug Administration Schedule, Humans, Longitudinal Studies, Middle Aged, Retrospective Studies, Risk Factors, Severity of Illness Index, Substance Withdrawal Syndrome, Suicide, Attempted, United States, Cohort Studies, Confounding Factors, Epidemiologic, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.